Molina Q4 2024 Earnings Report
Key Takeaways
Molina Healthcare reported strong Q4 2024 financial results, with premium revenue exceeding long-term targets and consolidated pre-tax margins within the target range. The company issued full year 2025 earnings guidance with expected premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share.
Q4 2024 GAAP earnings per diluted share were $4.44, and adjusted earnings per diluted share were $5.05.
Full year 2024 GAAP earnings per diluted share were $20.42, and adjusted earnings per diluted share were $22.65.
The company served approximately 5.5 million members as of December 31, 2024.
Full year 2025 earnings guidance includes expected premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share.
Molina
Molina
Molina Revenue by Segment
Forward Guidance
Molina Healthcare expects premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share for the full year 2025.
Positive Outlook
- Expected premium revenue of approximately $42 billion for the full year 2025, an increase of approximately 9% from the full year 2024.
- Full year GAAP earnings per share in 2025 expected to be at least $22.50 per share.
- Full year adjusted earnings per share in 2025 expected to be at least $24.50 per share, representing 8% growth over the full year 2024.
- Growth primarily reflects growth in the Company’s legacy footprint and continued realization of new store embedded earnings.
- Includes approximately $1.00 per diluted share of expected implementation costs in 2025 for recent Medicaid and Medicare Duals contract wins, and yields approximately 13% growth over 2024.
Challenges Ahead
- Approximately $1.00 per diluted share of expected implementation costs in 2025 for recent Medicaid and Medicare Duals contract wins.
- GAAP G&A Ratio of 7.2%.
- Adjusted G&A Ratio of 7.0%.
- Effective Tax Rate of 25.3%.
- GAAP After-tax Margin 2.8%.